NCT07833150Not yet recruiting
Balance Performance and Quality of Life in Parkinson's Disease
The Relationship Between Performance-Based Balance Tests and Quality of Life in Individuals With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population. Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 16 Sept 2026
- Start date
- Sept 2026
- Primary completion date
- Oct 2026
- Lead sponsor
- Pamukkale University
- Diseases
- Parkinson disease
- NCT number
- NCT07833150
What you commit to
- Study type: Observational
- Planned participants: 40
- From Sept 2026 to the primary completion date, Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Being a healthy individual matched for age and sex with a participant diagnosed with Parkinson's disease Willing to participate in the study and providing written informed consent Being 20 years of age or older
Who the study is looking for
- Willing to participate in the study and providing written informed consent
- Having a diagnosis of idiopathic Parkinson's disease
- Being 20 years of age or older
- Being classified as stage 1-3 according to the Modified Hoehn and Yahr Scale
- Being in the "on" medication state and undergoing assessment one hour after taking antiparkinsonian medication
Age in the registry: 20 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.